25 September 2018 in Dermatologic Therapy
28 April 2020 in Journal of the European Academy of Dermatology and Venereology
SRShivaprakash Rudramurthy
31 July 2019 in Dermatologic Therapy
4 September 2019 in International Journal of Dermatology
2 May 2020 in Dermatologic Therapy
Background Acne cysts are a common dermatological problem that often leads to scarring and a significant negative impact on patients’ psyche. Objective To report the usefulness of intralesional foam sclerotherapy for the treatment of cystic acne. Material and methods Patients with cystic acne treated with intralesional foam sclerotherapy between June 2018 and May 2019 were identified. Treatment response and adverse effects were assessed during follow‐up. Results Twelve patients (10 men and 2 women) with cystic acne with a median age of 21 years were treated during the study period. Of these 12 patients, eight (66.7%) showed complete resolution within 48 hours and two (16.7%) experienced complete resolution within 1 week. Two patients failed treatment at the end of the 4‐week follow‐up. Of the two patients with more than one acne cyst, response was noted only at the treated site. All patients who showed improvement sustained the effects at the 12‐week follow‐up. No adverse effects were observed and the treated sites healed with good cosmesis and minimal scarring. Conclusions and relevance Single‐session percutaneous polidocanol sclerotherapy is useful for the treatment of acne cysts. Future controlled studies are required to compare the efficacy of intralesional sclerotherapy with intralesional corticosteroids.